# Market Mayhem: Tickers in Turmoil!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2025-10-24T14:01:00.319Z
Source: https://newsyai.com/edition/21192b0b-3931-4a20-9d41-1beb2e7db2bd
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

# Market Brawl: Three Tickery Soap Operas (Oct 24, 2025)

The floor’s sticky, the takes are spicier than jalapeño options, and three tickers have bulls and bears screaming into their Bloomberg microphones. Grab your helmet.

---

## 1) Super Micro Computer (SMCI): “AI arms dealer” vs “calendar clown car”

Why it’s loud today
- SMCI cut its fiscal Q1 revenue outlook to ~$5B from $6–$7B, blaming customer delivery delays. Stock face‑planted intraday. They still reaffirmed full‑year “at least $33B.” Translation: trust me, bro… next quarter. ([wsj.com](https://www.wsj.com/tech/super-micro-trims-first-quarter-forecast-on-order-delays-bbfa05bb?utm_source=openai))

Bull case (liquid‑cooled hopium)
- AI build‑out is still a freight train. Demand for SMCI’s dense racks and liquid‑cooling kits keeps compounding; “pushed right, not cancelled” is the mantra. Full‑year guide above Street says the pipeline isn’t a mirage. ([wsj.com](https://www.wsj.com/tech/super-micro-trims-first-quarter-forecast-on-order-delays-bbfa05bb?utm_source=openai))

Bear case (credibility tax)
- Pre‑announce misses and slip‑and‑slide deliveries reopen the “can they forecast?” wound—especially after past governance/control hair. If big‑customer concentration forces pricing, margins get kneecapped while investors play calendar Tetris. ([investopedia.com](https://www.investopedia.com/supermicro-stock-dives-as-weak-preliminary-results-raise-credibility-concerns-jpmorgan-says-11724895?utm_source=openai))

My take, first principles
- AI servers are a physics + logistics business: watts → cooling → racks → facilities. When end customers hit power/real‑estate bottlenecks, integrators slip schedules—your revs slip with them. I’ll believe the full‑year only if: (1) backlog aging improves, (2) liquid‑cool capacity ramps with firm ship windows, (3) margin mix holds despite “elephant” deals. Until then, trade the tantrums: fade euphoric pops, buy panic when delays, not demand, drive the move. Keep it tight—this thing whips like a day‑trader’s neck. ([wsj.com](https://www.wsj.com/tech/super-micro-trims-first-quarter-forecast-on-order-delays-bbfa05bb?utm_source=openai))

---

## 2) Humana (HUM): “Defensive compounder” vs “actuarial migraine”

Why it’s loud lately
- After a brutal year of utilization spikes and a Medicare Advantage star‑ratings belly‑flop, Humana has been trying to stitch the patient back together. Recent updates: raised FY25 adjusted EPS outlook to ~$17, and Q2 printed better than feared. But 2026 star bonuses look lighter than a salad at a steakhouse. ([humana.gcs-web.com](https://humana.gcs-web.com/news-releases/news-release-details/humana-reports-second-quarter-2025-financial-results-raises-full?utm_source=openai))

Bull case (back to blocking and tackling)
- Benefit ratio tracking to plan, cost discipline improving, CenterWell driving script volume, and member losses smaller than feared. If stars recover into 2027, the earnings bridge re‑appears and the multiple gets its dignity back. ([humana.gcs-web.com](https://humana.gcs-web.com/news-releases/news-release-details/humana-reports-second-quarter-2025-financial-results-raises-full?utm_source=openai))

Bear case (the trend is not your friend)
- Stars down = fewer bonus dollars in 2026; inpatient and pharmacy utilization are sticky; CMS isn’t exactly tossing confetti. Any DOJ/industry overhang (see UNH probe) keeps a wet blanket on the whole MA cohort’s multiples. ([apnews.com](https://apnews.com/article/24c77d3535589eb1330777650d9faf3e?utm_source=openai))

My take, first principles
- Insurer math is delayed karma: price next year for costs you misjudged this year. The fix is time and repricing. My gating items: (1) Medicare Advantage benefit ratio <~90% by mid‑’26 trajectory, (2) concrete star‑rating rehab plan with contract‑level visibility, (3) proof that Marketplace/benefit tweaks don’t boomerang as churn. For now, it’s a “show me” swing long on capitulation days, with a stop tighter than hospital gowns. ([reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/humana-sees-20-its-members-high-rated-medicare-plans-2025-10-02/?utm_source=openai))

---

## 3) NextEra Energy (NEE): “AI power landlord” vs “rate‑sensitive renewables piñata”

Why it’s loud
- Mixed prints all year: revenue misses but profit holds up, backlog swells on hyperscaler/data‑center demand, and the XPLR/affiliate distribution drama early in ’25 spooked yield tourists. It’s the patron saint of growthy utilities—until rates twitch or policy wobbles. ([investopedia.com](https://www.investopedia.com/nextera-energy-tops-profit-estimates-as-ai-data-center-demand-booms-though-revenue-misses-11777388?utm_source=openai))

Bull case (wires, watts, and workloads)
- Data centers are a secular power hog. NEE keeps adding GW to backlog and re‑affirming multi‑year EPS targets. Florida Power & Light throws off stable cash; renewables + storage bookings keep compounding. ([investopedia.com](https://www.investopedia.com/nextera-energy-tops-profit-estimates-as-ai-data-center-demand-booms-though-revenue-misses-11777388?utm_source=openai))

Bear case (spreadsheet sobriety)
- Higher capex, supply‑chain/tariff noise, and affiliate shocks can jar the equity story. If rates back up or policy gets quirky, the multiple compresses faster than a cheap extension cord on a server farm. ([reuters.com](https://www.reuters.com/business/energy/nextera-energy-posts-lower-fourth-quarter-profit-2025-01-24/?utm_source=openai))

My take, first principles
- Utility math: ROE on rate base vs funding cost; developer math: IRR vs cap stack. If AI‑driven load growth turns into approved rate base with timely recovery, you’ve got a beautiful, regulated flywheel. I want: (1) visibility that data‑center interconnects translate into FPL capex with allowed returns, (2) proof that tariff/IRA noise doesn’t nuke project IRRs, (3) no more affiliate “surprises.” Buy the dips when 10‑year yields scare tourists; trim when everyone pretends it’s a SaaS company with a substation. ([investopedia.com](https://www.investopedia.com/nextera-energy-tops-profit-estimates-as-ai-data-center-demand-booms-though-revenue-misses-11777388?utm_source=openai))

---

## The Quick Tape Tilt (what flips me fast)
- SMCI: Backlog aging improves and liquid‑cool deployments hit dates while gross margins don’t squish. Otherwise, sell pop/hedge. ([wsj.com](https://www.wsj.com/tech/super-micro-trims-first-quarter-forecast-on-order-delays-bbfa05bb?utm_source=openai))  
- HUM: Concrete star‑rating remediation plus sequential MLR improvement; if not, it’s a widowmaker bounce. ([reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/humana-sees-20-its-members-high-rated-medicare-plans-2025-10-02/?utm_source=openai))  
- NEE: Show me approved, remunerative data‑center capex flowing through FPL and no new affiliate drama. ([investopedia.com](https://www.investopedia.com/nextera-energy-tops-profit-estimates-as-ai-data-center-demand-booms-though-revenue-misses-11777388?utm_source=openai))

Not investment advice. Markets are a bar fight—protect your teeth, your stops, and your ego.
